Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.63041675
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

31.37 0.31 (1.00%)

117.85% Gain from 52W Low

1.9M

XNAS Volume

XNAS 06 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.2 / 100

Technically Moderately Bullish

61.1 / 100

1Yr Price target upside is 73%

15 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

117.85% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart